Pharmacology

The entire hive can be treated for common bacterial diseases

Current levels of pain management administration by dairy producers and veterinarians in Europe and North America are low.

Felixvet has introduced a carprofen therapy with the same therapeutic benefits as Rimadyl

Communications expert Wendy S. Myers provides scripts for confident client conversations

In a dvm360 interview, Lee Pope, DVM, shares what veterinarians most-often request of their patients' medications.

Zoetis has launched its’ 0.5 mL dose for intranasal Vanguard B

Longevity drug developer Loyal and pain therapy manufacturer Elanco Animal Health are working with the organization to promote the need for aging canine care and enhance veterinary resources.

Jb Minter, DVM, MS, DACZM, discusses potential complications that can arise when amphibians are under anesthesia

William Murphy, PhD, BS, was selected by SEC provosts for the recognition, from among 16 previous achievement award recipients

In this interview, Jb Minter, DVM, MS, DACZM, talks about amphibian metabolism, drug processing, and more

Felycin-CA1 manages ventricular hypertrophy in feline patients with subclinical hypertrophic cardiomyopathy

DuOtic received FDA approval March 2024 to treat canine patients

Casey Locklear, DVM, discussed the combination drug’s efficacy and administration of the therapy, during an interview with dvm360.

These natural and pharmaceutical therapies aid by reducing the reabsorption of sodium and water

Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session

Casey Locklear, DVM, discussed Credelio Quattro chewable tablets in a dvm360 interview.

Loyal’s developmental therapy aims to increase longevity and quality of life for senior dogs

The novel therapy is the first drug for treating cats with hypertrophic cardiomyopathy

Casey Locklear, DVM, discusses Elanco's new product Credelio Quattro, which will be featured at WVC 2025

American Regent Animal Health created the new resources in collaboration with the UC-Davis professor Denis Marcellin-Little, DEDV, DACVS, DACVSMR, DECVS

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

Approved by the FDA in January 2024, EquiCoxib is a noninvasive, liquid formulation.

The legislation seeks to empower law enforcement and fight the opioid epidemic while also protecting access to the drug for veterinary use

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.